From an engineering perspective, controlling blood glucose appears to be a fairly straightforward single input (glucose), single output (insulin) control problem. Unfortunately, mimicking Mother Nature turns out to be a complex endeavor. The primary hurdle in developing a useful, safe closed-loop control algorithm for an artificial pancreas is the time delays associated with current continuous glucose monitors and subcutaneously delivered insulins. This article will provide a brief history of the artificial pancreas, outline the main clinical hurdles restricting its current implementation, and list possible solutions for success.
AlbisserAMLeibelBSEwartTGDavidovacZBotzCKZinggWSchipperHGanderR. Clinical control of diabetes by the artificial pancreas. Diabetes.1974;23 (5): 397–404.
2.
ClemensAHChangPHMyersRW. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS). Horm Metab Res.1977; Suppl 7: 23–33.
WeinzimerSASteilGMSwanKLDziuraJKurtzNTamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care.2008;31 (5): 934–9.
5.
HeinemannL. Variability of insulin absorption and insulin action. Diabetes Technol Ther.2002;4 (5): 673–82.
6.
KumareswaranKHarrisJElleriDAllenJMNodaleMWestonJWilinskaMEDungerDBAmielSAHellerSREvansMLHovorkaR. Overnight closed loop (CL) glucose control following consumption of alcohol in adults with type 1 diabetes (T1D). ADA. 2010; Abstract 0358-OR.
7.
LudvikBKautzky-WillerAPragerRThomasethKPaciniG. Amylin: History and overview. Diabet Med.1997;14Suppl 2: S9–13
8.
LieblAHoogmaRRenardEGeelhoed-DuijvestijnPHKleinEDiglasJKesslerLMelkiVDiemPBrunJMSchaepelynck-BélicarPFreiT; European DiaPort Study Group. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obes Metab.2009;11 (11): 1001–8.
9.
BotzCKLeibelBSZinggWGanderREAlbisserAM. Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas). Diabetes.1976;25 (8): 691–700.
10.
KellerUSchadeDS. Current status of portable insulin infusion devices. Satellite workshop on portable insulin infusion devices. (Preceding the XVth annual meeting of the European Society for Clinical Investigation) 18–19 March 1981, Basel, Switzerland. Diabetologia.1981;21 (4): 425–6.
11.
GiaccaACaumoAGalimbertiGPetrellaGLibrentiMCScaviniMPozzaGMicossiP. Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects. J Clin Endocrinol Metab.1993;77 (3): 738–42.
12.
RenardEPlaceJCantwellMChevassusHPalermCC. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: Feasibility study testing a new model for the artificial pancreas. Diabetes Care.2010;33 (1): 121–7.
13.
RaveKPotockaEHeinemannLHeiseTBossAHMarinoMCostelloDChenR. Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab.2009;11 (7): 715–20.
14.
VaughnDEYocumRCMuchmoreDBSugarmanBJVickAMBilinskyIPFrostGI. Accelerated pharmacokinetics and gluco-dynamics of prandial insulins injected with recombinant human hyaluronidase. Diabetes Technol Ther.2009;11 (6): 345–52.
15.
FinanDAZisserHJovanovičLBevierWCSeborgDE. Automatic detection of stress states in type 1 diabetes subjects in ambulatory conditions. Ind Eng Chem Res.2010;49 (17): 7843–8.
16.
DassauEJovanovicLDoyleFJ3rdZisserHC. Enhanced 911/global position system wizard: A telemedicine application for the prevention of severe hypoglycemia–monitor, alert, and locate. J Diabetes Sci Technol.2009;3 (6): 1501–6.
17.
PeyserTZisserHKhanUJovanovičLBevierWRomeyMSuriJStrasmaPTiadenSGamseyS. Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus. J Diabetes Sci Technol.2011 May 1; 5 (3): 687–93.
18.
BantingFGBestCHCollipJBCampbellWRFletcherAA. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J.1922;12 (3): 141–6.
19.
KowalskiAJ. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: A roadmap to better diabetes outcomes. Diabetes Technol Ther.2009;11Suppl 1: S113–9
